16E Stock Overview
A medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
Episurf Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.0001 |
| 52 Week High | SEK 0.069 |
| 52 Week Low | SEK 0.0001 |
| Beta | 1.09 |
| 1 Month Change | -85.71% |
| 3 Month Change | -96.00% |
| 1 Year Change | -99.86% |
| 3 Year Change | -99.96% |
| 5 Year Change | -99.92% |
| Change since IPO | -99.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| 16E | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -2.4% | -0.6% |
| 1Y | -99.9% | -4.7% | 14.8% |
Return vs Industry: 16E underperformed the German Medical Equipment industry which returned -4.7% over the past year.
Return vs Market: 16E underperformed the German Market which returned 14.8% over the past year.
Price Volatility
| 16E volatility | |
|---|---|
| 16E Average Weekly Movement | 4,325.8% |
| Medical Equipment Industry Average Movement | 6.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.5% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 16E's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 16E's weekly volatility has decreased from 6773% to 4326% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 27 | Pal Ryfors | episurf.com |
Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient’s knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also provides Episealer Talus, a solution for the treatment of bone and cartilage defects in the talus bone of the ankle joint; Epioscopy to identify and visualize femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning.
Episurf Medical AB (publ) Fundamentals Summary
| 16E fundamental statistics | |
|---|---|
| Market cap | €6.24m |
| Earnings (TTM) | -€6.82m |
| Revenue (TTM) | €1.85m |
3.4x
P/S Ratio-0.9x
P/E RatioIs 16E overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 16E income statement (TTM) | |
|---|---|
| Revenue | SEK 20.60m |
| Cost of Revenue | SEK 9.90m |
| Gross Profit | SEK 10.70m |
| Other Expenses | SEK 86.70m |
| Earnings | -SEK 76.00m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Mar 06, 2025
| Earnings per share (EPS) | -0.12 |
| Gross Margin | 51.94% |
| Net Profit Margin | -368.93% |
| Debt/Equity Ratio | 0% |
How did 16E perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/23 08:43 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Episurf Medical AB (publ) is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yilmaz Mahshid | Pareto Securities |
| Anders Hedlund | Redeye |
| John Westborg | Redeye |